82 related articles for article (PubMed ID: 16323251)
1. Cognitive correlates of brain MRI subcortical signal hyperintensities in non-demented elderly.
Marshall GA; Hendrickson R; Kaufer DI; Ivanco LS; Bohnen NI
Int J Geriatr Psychiatry; 2006 Jan; 21(1):32-5. PubMed ID: 16323251
[TBL] [Abstract][Full Text] [Related]
2. Heterogeneity of white matter hyperintensities in Alzheimer's disease: post-mortem quantitative MRI and neuropathology.
Gouw AA; Seewann A; Vrenken H; van der Flier WM; Rozemuller JM; Barkhof F; Scheltens P; Geurts JJ
Brain; 2008 Dec; 131(Pt 12):3286-98. PubMed ID: 18927145
[TBL] [Abstract][Full Text] [Related]
3. Neuroimaging and correlates of cognitive function among patients with heart failure.
Vogels RL; Oosterman JM; van Harten B; Gouw AA; Schroeder-Tanka JM; Scheltens P; van der Flier WM; Weinstein HC
Dement Geriatr Cogn Disord; 2007; 24(6):418-23. PubMed ID: 17938570
[TBL] [Abstract][Full Text] [Related]
4. Automated and visual scoring methods of cerebral white matter hyperintensities: relation with age and cognitive function.
Tiehuis AM; Vincken KL; Mali WP; Kappelle LJ; Anbeek P; Algra A; Biessels GJ
Cerebrovasc Dis; 2008; 25(1-2):59-66. PubMed ID: 18033959
[TBL] [Abstract][Full Text] [Related]
5. The role of white matter hyperintensities and medial temporal lobe atrophy in age-related executive dysfunctioning.
Oosterman JM; Vogels RL; van Harten B; Gouw AA; Scheltens P; Poggesi A; Weinstein HC; Scherder EJ
Brain Cogn; 2008 Nov; 68(2):128-33. PubMed ID: 18450353
[TBL] [Abstract][Full Text] [Related]
6. Cognitive dysfunction associates with white matter hyperintensities and subcortical atrophy on magnetic resonance imaging of the elderly diabetes mellitus Japanese elderly diabetes intervention trial (J-EDIT).
Akisaki T; Sakurai T; Takata T; Umegaki H; Araki A; Mizuno S; Tanaka S; Ohashi Y; Iguchi A; Yokono K; Ito H
Diabetes Metab Res Rev; 2006; 22(5):376-84. PubMed ID: 16506272
[TBL] [Abstract][Full Text] [Related]
7. Neuropathologic correlates of white matter hyperintensities.
Young VG; Halliday GM; Kril JJ
Neurology; 2008 Sep; 71(11):804-11. PubMed ID: 18685136
[TBL] [Abstract][Full Text] [Related]
8. White matter hyperintensities do not impact cognitive function in patients with newly diagnosed Parkinson's disease.
Dalaker TO; Larsen JP; Dwyer MG; Aarsland D; Beyer MK; Alves G; Bronnick K; Tysnes OB; Zivadinov R
Neuroimage; 2009 Oct; 47(4):2083-9. PubMed ID: 19539037
[TBL] [Abstract][Full Text] [Related]
9. White matter hyperintensities and working memory: an explorative study.
Oosterman JM; Van Harten B; Weinstein HC; Scheltens P; Sergeant JA; Scherder EJ
Neuropsychol Dev Cogn B Aging Neuropsychol Cogn; 2008 May; 15(3):384-99. PubMed ID: 18421629
[TBL] [Abstract][Full Text] [Related]
10. MTI of white matter hyperintensities.
Fazekas F; Ropele S; Enzinger C; Gorani F; Seewann A; Petrovic K; Schmidt R
Brain; 2005 Dec; 128(Pt 12):2926-32. PubMed ID: 15958507
[TBL] [Abstract][Full Text] [Related]
11. Magnetic resonance imaging white matter hyperintensities and brain volume in the prediction of mild cognitive impairment and dementia.
Smith EE; Egorova S; Blacker D; Killiany RJ; Muzikansky A; Dickerson BC; Tanzi RE; Albert MS; Greenberg SM; Guttmann CR
Arch Neurol; 2008 Jan; 65(1):94-100. PubMed ID: 18195145
[TBL] [Abstract][Full Text] [Related]
12. Imaging age-related cognitive decline: A comparison of diffusion tensor and magnetization transfer MRI.
Schiavone F; Charlton RA; Barrick TR; Morris RG; Markus HS
J Magn Reson Imaging; 2009 Jan; 29(1):23-30. PubMed ID: 19097099
[TBL] [Abstract][Full Text] [Related]
13. Behavioural and psychological symptoms are not related to white matter hyperintensities and medial temporal lobe atrophy in Alzheimer's disease.
Staekenborg SS; Gillissen F; Romkes R; Pijnenburg YA; Barkhof F; Scheltens P; van der Flier WM
Int J Geriatr Psychiatry; 2008 Apr; 23(4):387-92. PubMed ID: 17907266
[TBL] [Abstract][Full Text] [Related]
14. Strategic subcortical hyperintensities in cholinergic pathways and executive function decline in treated Alzheimer patients.
Behl P; Bocti C; Swartz RH; Gao F; Sahlas DJ; Lanctot KL; Streiner DL; Black SE
Arch Neurol; 2007 Feb; 64(2):266-72. PubMed ID: 17296844
[TBL] [Abstract][Full Text] [Related]
15. White matter hyperintensities and within-person variability in community-dwelling adults aged 60-64 years.
Bunce D; Anstey KJ; Christensen H; Dear K; Wen W; Sachdev P
Neuropsychologia; 2007 May; 45(9):2009-15. PubMed ID: 17382358
[TBL] [Abstract][Full Text] [Related]
16. The relation of white matter hyperintensities to cognitive performance in the normal old: education matters.
Nebes RD; Meltzer CC; Whyte EM; Scanlon JM; Halligan EM; Saxton JA; Houck PR; Boada FE; Dekosky ST
Neuropsychol Dev Cogn B Aging Neuropsychol Cogn; 2006; 13(3-4):326-40. PubMed ID: 16887777
[TBL] [Abstract][Full Text] [Related]
17. [Interest of a new instrument to assess cognition in schizophrenia: The Brief Assessment of Cognition in Schizophrenia (BACS)].
Bralet MC; Navarre M; Eskenazi AM; Lucas-Ross M; Falissard B
Encephale; 2008 Dec; 34(6):557-62. PubMed ID: 19081451
[TBL] [Abstract][Full Text] [Related]
18. Increased rates of white matter hyperintensities in late-onset bipolar disorder.
Tamashiro JH; Zung S; Zanetti MV; de Castro CC; Vallada H; Busatto GF; de Toledo Ferraz Alves TC
Bipolar Disord; 2008 Nov; 10(7):765-75. PubMed ID: 19032708
[TBL] [Abstract][Full Text] [Related]
19. White matter hyperintensities in subjects with cocaine and opiate dependence and healthy comparison subjects.
Lyoo IK; Streeter CC; Ahn KH; Lee HK; Pollack MH; Silveri MM; Nassar L; Levin JM; Sarid-Segal O; Ciraulo DA; Renshaw PF; Kaufman MJ
Psychiatry Res; 2004 Jul; 131(2):135-45. PubMed ID: 15313520
[TBL] [Abstract][Full Text] [Related]
20. White matter hyperintensities and chronicity of depression.
Heiden A; Kettenbach J; Fischer P; Schein B; Ba-Ssalamah A; Frey R; Naderi MM; Gulesserian T; Schmid D; Trattnig S; Imhof H; Kasper S
J Psychiatr Res; 2005 May; 39(3):285-93. PubMed ID: 15725427
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
